CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 488143-488324 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T61653","span":{"begin":0,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"After 6 months of IFN-beta-1b 250 mcg treatment, patients with persisting disease activity were randomized to either continue on 250 mcg dose or receive an increased dose (375 mcg)."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T102","span":{"begin":0,"end":181},"obj":"Sentence"}],"text":"After 6 months of IFN-beta-1b 250 mcg treatment, patients with persisting disease activity were randomized to either continue on 250 mcg dose or receive an increased dose (375 mcg)."}